0001209191-15-070808.txt : 20150915 0001209191-15-070808.hdr.sgml : 20150915 20150915173457 ACCESSION NUMBER: 0001209191-15-070808 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150914 FILED AS OF DATE: 20150915 DATE AS OF CHANGE: 20150915 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONCERT PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001367920 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 99 HAYDEN AVENUE STREET 2: SUITE 500 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-860-0045 MAIL ADDRESS: STREET 1: 99 HAYDEN AVENUE STREET 2: SUITE 500 CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: CONCERT PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060628 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McGowan Pauline CENTRAL INDEX KEY: 0001594782 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36310 FILM NUMBER: 151108495 MAIL ADDRESS: STREET 1: 99 HAYDEN AVENUE, SUITE 500 CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-09-14 0 0001367920 CONCERT PHARMACEUTICALS, INC. CNCE 0001594782 McGowan Pauline C/O CONCERT PHARMACEUTICALS, INC. 99 HAYDEN AVENUE, SUITE 500 LEXINGTON MA 02421 0 1 0 0 VP, Finance Common Stock 2015-09-14 4 M 0 497 3.50 A 497 D Common Stock 2015-09-14 4 S 0 497 18.9745 D 0 D Employee Stock Option (right to buy) 3.50 2015-09-14 4 M 0 497 0.00 D 2021-12-12 Common Stock 497 498 D This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014. Represents the weighted average sales price for shares sold in multiple transactions. Sales prices ranged from $18.79 to $19.25 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price This option vested as to 6.25% of the original 7,964 shares on March 12, 2012 and vests as to an additional 6.25% of the original shares at the end of each successive three-month period through and including December 12, 2015. /s/ Pauline McGowan 2015-09-15